These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 25553169)

  • 1. Complete response to ethnylestradiol prolonged for almost two years in patients with castration-resistant prostate cancer.
    Hongo H; Kosaka T; Oya M
    Can Urol Assoc J; 2014 Nov; 8(11-12):E921-3. PubMed ID: 25553169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete Response to Bicalutamide Withdrawal Prolonged for Almost 2 Years in Patients With Metastatic Prostate Cancer.
    Hongo H; Kosaka T; Oya M
    Urol Case Rep; 2014 Sep; 2(5):150-1. PubMed ID: 26958470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report.
    Sano M; Yamamoto S; Uehara S; Yuasa T; Masuda H; Fukui I; Yonese J
    Mol Clin Oncol; 2016 Sep; 5(3):208-210. PubMed ID: 27588183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COMPLETE RESPONSE OF BULKY LYMPH NODE METASTASES TREATED WITH ENZALUTAMIDE AFTER CHEMOTHERAPY WITH DOCETAXEL IN CASTRATION-RESISTANT PROSTATE CANCER: A CASE REPORT].
    Ishii T; Ide T; Miyajima T; Tominaga K; Miyajima S; Taira H; Haraoka S
    Nihon Hinyokika Gakkai Zasshi; 2019; 110(3):201-205. PubMed ID: 32684582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flutamide withdrawal plus hydrocortisone resulted in clinical complete response in a patient with prostate carcinoma.
    Figg WD; Kroog G; Duray P; Walther MM; Patronas N; Sartor O; Reed E
    Cancer; 1997 May; 79(10):1964-8. PubMed ID: 9149024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abiraterone acetate withdrawal syndrome: Speculations on the underlying mechanisms.
    Kato T; Komiya A; Yuasa J; Kaga K; Kaga M; Kojima S; Naya Y; Isaka S
    Oncol Lett; 2018 Feb; 15(2):2669-2672. PubMed ID: 29434990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete response with early introduction of cabazitaxel in a patient with multiple lung metastases of castration-resistant prostate cancer following the early detection of metastases using liquid biopsy: a case report.
    Kosaka T; Hongo H; Oya M
    BMC Cancer; 2019 Jun; 19(1):562. PubMed ID: 31185946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate-specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration-resistant prostate cancer.
    Kijima T; Fujii Y; Yokoyama M; Ishioka J; Matsuoka Y; Numao N; Saito K; Koga F; Masuda H; Kawakami S; Kihara K
    BJU Int; 2012 Oct; 110(8):1149-55. PubMed ID: 22369348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bicalutamide 150 mg as secondary hormonal therapy for castration-resistant prostate cancer.
    Qian SB; Shen HB; Cao QF; Zhang L; Chen YF; Qi J
    Int Urol Nephrol; 2015 Mar; 47(3):479-84. PubMed ID: 25665794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate specific antigen decreases after withdrawal of antiandrogen therapy with bicalutamide or flutamide in patients receiving combined androgen blockade.
    Schellhammer PF; Venner P; Haas GP; Small EJ; Nieh PT; Seabaugh DR; Patterson AL; Klein E; Wajsman Z; Furr B; Chen Y; Kolvenbag GJ
    J Urol; 1997 May; 157(5):1731-5. PubMed ID: 9112515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of ductal carcinoma of the prostate after transurethral resection of prostate].
    Izumi K; Kanno H; Umemoto S; Hasumi H; Osada Y; Ota J; Tsuchiya F; Ogino I; Harada M
    Hinyokika Kiyo; 2007 May; 53(5):315-8. PubMed ID: 17561717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Estramustine phosphate withdrawal syndrome in relapsed prostate cancer: two case reports].
    Kobayashi S; Tsukamoto T; Tohsaka A; Tohma T
    Hinyokika Kiyo; 2008 Jun; 54(6):423-6. PubMed ID: 18634439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of preoperative serum prostate-specific antigen concentration and biopsy Gleason score in predicting risk of pelvic lymph node metastases in prostate cancer.
    Narayan P; Fournier G; Gajendran V; Leidich R; Lo R; Wolf JS; Jacob G; Nicolaisen G; Palmer K; Freiha F
    Urology; 1994 Oct; 44(4):519-24. PubMed ID: 7524237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.
    Kato T; Kojima S; Fujimoto A; Otsuka K; Suyama T; Hou K; Araki K; Masuda H; Yamazaki K; Komiya A; Naya Y
    Oncol Lett; 2018 Oct; 16(4):5383-5388. PubMed ID: 30250608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptomeningeal Metastases in a Patient with Castration-Resistant Prostate Cancer.
    Koie T; Hashimoto Y; Suzuki Y; Hatayama Y; Kimura F
    Case Rep Urol; 2020; 2020():5627548. PubMed ID: 33005471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data.
    Teh BS; Ayala G; Aguilar L; Mai WY; Timme TL; Vlachaki MT; Miles B; Kadmon D; Wheeler T; Caillouet J; Davis M; Carpenter LS; Lu HH; Chiu JK; Woo SY; Thompson T; Aguilar-Cordova E; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1520-9. PubMed ID: 15050332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic prostate cancer in an asymptomatic patient with an initial prostate-specific antigen (PSA) serum concentration of 21,380 ng/ml.
    Persec Z; Persec J; Sović T; Romic Z; Bosnar Herak M; Hrgovic Z
    Onkologie; 2010; 33(3):110-2. PubMed ID: 20215802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare case of isolated castrate resistant bilateral testicular metastases in advanced prostate cancer.
    Su J; Aslim EJ; Aydin H; Tan PH; Ho HSS
    Asian J Urol; 2018 Apr; 5(2):127-130. PubMed ID: 29736376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.